Insider · CIK 0002102721
Holly B. Kordasiewicz
Files at IONS (IONIS PHARMACEUTICALS INC). First filing Jan 20, 2026, latest Jun 16, 2026.
Holly B. Kordasiewicz files SEC Form 4 as officer at IONS (IONIS PHARMACEUTICALS INC). Since Jan 20, 2026, Holly B. Kordasiewicz has reported 0 open-market buys worth $0 and 2 open-market sells worth $4.8M, the latest filed on Jun 16, 2026.
A track record needs three past buys with six months of prices behind them; Holly B. Kordasiewicz has 0, so none is measured yet.
The newest scored trade: sold $4.5M of IONS on Jun 12, 2026, filed Jun 16, 2026, scored 40 (moderate), under a 10b5-1 plan. In the last 12 months: 0 buys worth $0 and 2 sells worth $4.8M.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
IONS: IONIS PHARMACEUTICALS INC
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 40Moderate | IONIS PHARMACEUTICALS INC | $4.5M 60,846 shares | -73% | +108% from low-15% from high | |
| 34Weak | IONIS PHARMACEUTICALS INC | $313k 4,141 shares | -22% | +199% from low-8% from high |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Jun 12, 2026 | IONS IONIS PHARMACEUTICALS INC | 60,846 0.04% of outstanding | $4.5M | Jun 12, 2026 | none |
| Jan 16, 2026 | IONS IONIS PHARMACEUTICALS INC | 4,141 0.00% of outstanding | $315k | Jan 16, 2025 | none |
Transactions
Every row this insider has filed, 17 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 12, 2026 | IONS IONIS PHARMACEUTICALS INC | MOption exercise Common Stock10b5-1 | +7,951 | $60.89 | $484k | 30,409 | Jun 16, 2026 |
| Jun 12, 2026 | IONS IONIS PHARMACEUTICALS INC | MOption exercise Common Stock10b5-1 | +21,000 | $60.89 | $1.3M | 51,409 | Jun 16, 2026 |
| Jun 12, 2026 | IONS IONIS PHARMACEUTICALS INC | MOption exercise Common Stock10b5-1 | +12,000 | $32.60 | $391k | 63,409 | Jun 16, 2026 |
| Jun 12, 2026 | IONS IONIS PHARMACEUTICALS INC | MOption exercise Common Stock10b5-1 | +19,895 | $56.78 | $1.1M | 83,304 | Jun 16, 2026 |
| Jun 12, 2026 | IONS IONIS PHARMACEUTICALS INC | SOpen-market sale Common Stock10b5-1 | -41,004 | $73.09 | $3.0M | 42,300 | Jun 16, 2026 |
| Jun 12, 2026 | IONS IONIS PHARMACEUTICALS INC | SOpen-market sale Common Stock10b5-1 | -19,842 | $74.05 | $1.5M | 22,458 | Jun 16, 2026 |
| Jun 12, 2026 | IONS IONIS PHARMACEUTICALS INC | MOption exercise Non-Qualified Stock Option (right to buy)derivative10b5-1 | -12,000 | $0.00 | $0 | 0 | Jun 16, 2026 |
| Jun 12, 2026 | IONS IONIS PHARMACEUTICALS INC | MOption exercise Non-Qualified Stock Option (right to buy)derivative10b5-1 | -19,895 | $0.00 | $0 | 0 | Jun 16, 2026 |
| Jun 12, 2026 | IONS IONIS PHARMACEUTICALS INC | MOption exercise Non-Qualified Stock Option (right to buy)derivative10b5-1 | -7,951 | $0.00 | $0 | 21,000 | Jun 16, 2026 |
| Jun 12, 2026 | IONS IONIS PHARMACEUTICALS INC | MOption exercise Non-Qualified Stock Option (right to buy)derivative10b5-1 | -21,000 | $0.00 | $0 | 0 | Jun 16, 2026 |
| Jan 15, 2026 | IONS IONIS PHARMACEUTICALS INC | MOption exercise Common Stock | +11,119 | $0.00 | $0 | 18,859 | Jan 20, 2026 |
| Jan 2, 2026 | IONS IONIS PHARMACEUTICALS INC | AGrant or award Non-Qualified Stock Option (right to buy)derivative | +7,500 | $0.00 | $0 | 16,600 | Jan 20, 2026 |
| Jan 16, 2026 | IONS IONIS PHARMACEUTICALS INC | SOpen-market sale Common Stock | -4,141 | $75.66 | $313k | 14,718 | Jan 20, 2026 |
| Jan 15, 2026 | IONS IONIS PHARMACEUTICALS INC | MOption exercise Restricted Stock Unitderivative | -11,119 | $0.00 | $0 | 20,830 | Jan 20, 2026 |
| Jan 15, 2026 | IONS IONIS PHARMACEUTICALS INC | AGrant or award Restricted Stock Unitderivative | +13,650 | $0.00 | $0 | 34,480 | Jan 20, 2026 |
| Jan 15, 2026 | IONS IONIS PHARMACEUTICALS INC | AGrant or award Restricted Stock Unitderivative | +11,250 | $0.00 | $0 | 45,730 | Jan 20, 2026 |
| Jan 2, 2026 | IONS IONIS PHARMACEUTICALS INC | AGrant or award Non-Qualified Stock Option (right to buy)derivative | +9,100 | $0.00 | $0 | 9,100 | Jan 6, 2026 |
Questions about Holly B. Kordasiewicz
Answered from the filings on this page, as of the latest one.
Is Holly B. Kordasiewicz buying or selling?
In the last 12 months Holly B. Kordasiewicz reported 0 open-market buys worth $0 and 2 open-market sells worth $4.8M on SEC Form 4; the latest was sold $4.5M of IONS on Jun 12, 2026. Grants, option exercises and tax withholding are not counted.
How did Holly B. Kordasiewicz's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Holly B. Kordasiewicz has 0.
Where does Holly B. Kordasiewicz file Form 4?
Holly B. Kordasiewicz has filed Form 4 at IONS (IONIS PHARMACEUTICALS INC) as EVP, Chief Development Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.